© 2017 Bessemer Venture Partners
All Rights Reserved
An investor in biotech companies.
Christopher Gabrieli is a Partner at Bessemer Venture Partners.
A biopharmaceutical company developing novel therapeutics to modulate the growth of tissues including bone and muscle.
AccuVein is a medical device company that uses optical technology to help facilitate venous access. It operates the world's only handheld, non-contact vein illumination solution and is used in over 700 hospitals today.
Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Affymax (NASDAQ: AFFY) went public in 2006.
Alcresta Pharmaceuticals develops enzyme-based products for people with gastrointestinal disorders and rare diseases.
Allena Pharmaceuticals, Inc. is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.
Allscripts provides innovative solutions such as Electronic Medical Records (EMRs) that empower all stakeholders across the healthcare continuum to deliver world-class outcomes. The company went public in July 1999 (NASDAQ:MDRX).
Develops non-systemic, protein therapeutics to treat metabolic and inflammatory diseases. In 2010 it was acquired by Eli Lilly and Company (NYSE:LLY).
Used high-throughput computer screening to develop drugs more quickly.
Aveo Pharmaceuticals integrates a proprietary cancer biology platform with drug development and commercial expertise in its efforts to discover and develop targeted cancer therapeutics.
Bright Health is a consumer focused health plan offering simple and affordable health insurance.
Cerulean Pharma Inc. is a clinical-stage biopharmaceutical company specializing in the design and development of nanopharmaceuticals. The company went public in April 2014 (NASDAQ: CERU).
Manufacturer of computer-based medical diagnostic equipment.
Cloud-based home care software provider.
Docent Health helps health systems transform the patient experience by delivering human-centric care.
DocuTAP provides electronic medical record, practice management software and revenue cycle services for urgent care centers. The company was acquired by Warburg Pincus in 2016.
Developed mechanisms to deliver smaller doses of drugs specifically to their targets.
Produced proprietary drug-delivery technology for the development of safe and practical biopharmaceuticals.
Develops imaging agents for use in MRIs.
Developing novel treatments for muscle cramps and spasms by halting repetitive firing of motor neurons. In January 2015, Flex Pharma went public (NASDAQ: FLKS).
Provides a comparison platform to help customers find affordable health insurance.
Developed software that facilitated the medical insurance payment process by translating medical terms into codes.
Health Essentials provides post-acute care management services.
Developer of treatments for allergies and auto-immune diseases.
IPC is the nation's leading national physician group practice focused on the delivery of hospital medicine and related facility-based services.
Isis is the leader in antisense drug development with a broad pipeline of drugs that are applicable to many different disease targets.
Liazon is the leading private benefit exchange provider for small and medium sized businesses. In November 2013, Liazon was acquired by Towers Watson & Co. (NYSE, NASDAQ: TW).
MediAssist is a Third Party Administrator of health insurance policies.
Developer of anti-viral, anti-bacterial and anti-cancer compounds.
NephroPlus is a well established chain of kidney care clinics that is shaping quality kidney care all over India.
The trusted partner for health and human services' largest connected community of providers and payers, Netsmart provides comprehensive financial, clinical and management solutions for healthcare delivery organizations. In June 2010 it was acquired by Genstar Capital.
Developer of innovative therapeutics.
Maker of food additives founded in 1987 as part of Enzytech, a biopharmaceutical research company.
OvaSciences is a healthcare company focused on improving fertility. Ovascience (NASDAQ: OVAS) started trading on the Over The Counter Bulletin Board (OTCBB) in November 2012 and listed on the Nasdaq in April 2013.
Oxagen is focused on becoming a significant biopharmaceutical company, developing a pipeline of novel drugs to treat inflammatory diseases, initially asthma.
Developed and manufactured an integrated system that reduced the time and cost of drug discoveries.
Proteon Therapeutics, Inc is a biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with renal and vascular diseases.
Remedinet Technologies is a leading provider of software solutions focused on healthcare information exchange and authentication.
Rock Health is a seed fund and startup accelerator focused on digital healthcare companies.
Develops software and services that streamline lab-supply purchases and lab-operations management.
A biopharmaceutical firm developing enzymes that activate our natural defenses against disease.
Stromedix's initial focus is on chronic indications and plans to leverage its expertise and expand its therapeutic pipeline into related settings such as acute organ failure and cancer. In 2012, Stromedix was acquired by Biogen Idec (NASDAQ: BIIB).
Insmed Incorporated (NASDAQ: INSM) is a development stage biopharmaceutical company with expertise in proprietary, advanced liposomal technology designed specifically for inhalation lung delivery.
TravCorps provides healthcare professionals for temporary and permanent assignments. Today, TravCorps provides registered nurses to more than 2,500 healthcare facilities across the U.S. and the Caribbean.
Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. In January 2012, Verastem went public (NASDAQ: VSTM).
A leading hospice care provider.
A health optimization platform that is revolutionizing the way population health managers align consumer actions and behaviors with the right incentives and rewards.